Sumitomo Pharma Co Ltd
F:DPM
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
S
|
Sumitomo Pharma Co Ltd
F:DPM
|
JP |
|
L
|
Legal & General Group PLC
F:LGI
|
UK |
|
F3 Uranium Corp
F:GL7
|
CA |
|
S
|
Smiths Group PLC
F:QS2A
|
UK |
|
PPC Ltd
OTC:PPCLY
|
ZA |
|
S
|
Smiths Group PLC
XMUN:QS2A
|
UK |
|
ABC Arbitrage SA
PAR:ABCA
|
FR |
|
C
|
CVS Group PLC
F:4C9
|
UK |
|
K
|
Koppers Holdings Inc
F:KO9
|
US |
|
C
|
Cadeler A/S
F:CA2
|
DK |
|
Lintec Corp
F:57T
|
JP |
|
H
|
Heroux Devtek Inc
F:5D6
|
CA |
|
Kinsale Capital Group Inc
F:KCH
|
US |
|
S
|
Sumitomo Pharma Co Ltd
DUS:DPM
|
JP |
|
M
|
Mitra Adiperkasa Tbk PT
OTC:PMDKF
|
ID |
|
Cikarang Listrindo Tbk PT
F:B2O
|
ID |
|
S
|
Sicily By Car SpA
MIL:SBC
|
IT |
Bankruptcy Probability
Sumitomo Pharma Co Ltd's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Sumitomo Pharma Co Ltd Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| JP |
|
Sumitomo Pharma Co Ltd
TSE:4506
|
685B JPY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
1T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
563.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| JP |
|
Hisamitsu Pharmaceutical Co Inc
TSE:4530
|
70.4T JPY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Roche Holding AG
SIX:ROG
|
248.4B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
230.9B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
285.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
204B GBP |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
265.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CA |
|
Nuvo Pharmaceuticals Inc
TSX:MRV
|
343.7B CAD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.3T DKK |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Sumitomo Pharma Co Ltd's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Sumitomo Pharma Co Ltd has total debt of 259B JPY. This includes both short-term (0 JPY) and long-term (259B JPY) debt.
You can find a full breakdown on its Balance Sheet.
